#BEGIN_DRUGCARD DB02282

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
17509

# Chemical_Formula:
C11H15N5O3S

# Chemical_IUPAC_Name:
(2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-[(methylsulfanyl)methyl]oxolane-3,4-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antimalarials
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
5'-Deoxy-5'-Methylthioadenosine

# HET_ID:
MTA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8+,11+/m0/s1

# InChI_Key:
InChIKey=WUUGFSXJNOTRMR-WOIOKPISSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2282

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
297.334

# Molecular_Weight_Mono:
297.089560061

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JDT

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.14

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
6.50e+00 g/l

# Primary_Accession_No:
DB02282

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
688097

# PubChem_Substance_ID:
46508330

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02241

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CSC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:58 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X16456

# Drug_Target_1_GenBank_ID_Protein:
46455

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rsrIM

# Drug_Target_1_Gene_Sequence:
>960 bp
ATGGCAAACCGATCTCACCACAATGCGGGCCACCGAGCGATGAACGCTCTCCGCAAGTCA
GGCCAAAAGCATTCGTCCGAGTCTCAGTTGGGATCTTCGGAGATCGGAACCACACGACAT
GTGTATGACGTTTGCGATTGCCTCGACACCTTGGCGAAGCTGCCCGACGACTCCGTCCAG
TTGATCATTTGTGATCCTCCATACAACATCATGCTGGCGGACTGGGATGATCACATGGAC
TACATCGGCTGGGCGAAGCGATGGCTAGCCGAAGCCGAGCGTGTTCTATCCCCAACGGGC
AGCATAGCGATTTTCGGCGGCCTACAATACCAAGGGGAGGCTGGTTCAGGTGATCTGATC
TCAATCATTTCGCACATGAGACAAAACAGCAAAATGCTGCTCGCAAACCTTATCATCTGG
AACTATCCGAACGGCATGAGTGCGCAGCGCTTCTTTGCAAATAGGCACGAGGAAATCGCG
TGGTTCGCCAAGACCAAGAAGTATTTCTTCGATCTTGACGCTGTGCGGGAACCATATGAC
GAGGAAACCAAAGCCGCTTACATGAAGGACAAGCGGTTGAACCCTGAGTCGGTTGAAAAG
GGACGCAACCCAACAAACGTGTGGCGGATGTCTCGGCTTAACGGCAATTCTCTTGAACGT
GTCGGCCACCCCACGCAAAAACCAGCCGCAGTGATTGAGAGACTGGTTCGCGCGTTGTCG
CATCCGGGTTCAACGGTCCTCGATTTTTTTGCTGGAAGTGGGGTAACGGCGCGCGTTGCA
ATTCAAGAGGGACGGAACAGCATTTGCACTGACGCCGCGCCTGTATTCAAAGAATATTAC
CAGAAGCAGCTAACTTTCCTTCAAGATGATGGACTGATCGACAAAGCGCGATCATATGAA
ATTGTTGAAGGGGCTGCGAACTTTGGTGCAGCATTGCAGCGGGGAGATGTTGCTTCATAA

# Drug_Target_1_General_Function:
Replication, recombination and repair

# Drug_Target_1_General_References:
11024175	Scavetta RD, Thomas CB, Walsh MA, Szegedi S, Joachimiak A, Gumport RI, Churchill ME: Structure of RsrI methyltransferase, a member of the N6-adenine beta class of DNA methyltransferases. Nucleic Acids Res. 2000 Oct 15;28(20):3950-61.
2602165	Stephenson FH, Greene PJ: Nucleotide sequence of the gene encoding the RsrI methyltransferase. Nucleic Acids Res. 1989 Dec 25;17(24):10503.
2690017	Kaszubska W, Aiken C, O'Connor CD, Gumport RI: Purification, cloning and sequence analysis of RsrI DNA methyltransferase: lack of homology between two enzymes, RsrI and EcoRI, that methylate the same nucleotide in identical recognition sequences. Nucleic Acids Res. 1989 Dec 25;17(24):10403-25.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2653

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
35656

# Drug_Target_1_Name:
Modification methylase RsrI

# Drug_Target_1_Number_of_Residues:
319

# Drug_Target_1_PDB_ID:
1NW7

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01555	N6_N4_Mtase

# Drug_Target_1_Protein_Sequence:
>Modification methylase RsrI
MANRSHHNAGHRAMNALRKSGQKHSSESQLGSSEIGTTRHVYDVCDCLDTLAKLPDDSVQ
LIICDPPYNIMLADWDDHMDYIGWAKRWLAEAERVLSPTGSIAIFGGLQYQGEAGSGDLI
SIISHMRQNSKMLLANLIIWNYPNGMSAQRFFANRHEEIAWFAKTKKYFFDLDAVREPYD
EETKAAYMKDKRLNPESVEKGRNPTNVWRMSRLNGNSLERVGHPTQKPAAVIERLVRALS
HPGSTVLDFFAGSGVTARVAIQEGRNSICTDAAPVFKEYYQKQLTFLQDDGLIDKARSYE
IVEGAANFGAALQRGDVAS

# Drug_Target_1_Reaction:
S-adenosyl-L-methionine + DNA adenine = S-adenosyl-L-homocysteine + DNA 6-methylaminopurine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
This methylase recognizes the double-stranded sequence GAATTC, causes specific methylation on A-? on both strands, and protects the DNA from cleavage by the RsrI endonuclease

# Drug_Target_1_SwissProt_ID:
P14751

# Drug_Target_1_SwissProt_Name:
MTR1_RHOSH

# Drug_Target_1_Synonyms:
Adenine-specific methyltransferase RsrI
EC 2.1.1.72
M.RsrI

# Drug_Target_1_Theoretical_pI:
7.06

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
MTAP

# Drug_Target_2_GenBank_ID_Gene:
U22233

# Drug_Target_2_GenBank_ID_Protein:
847724

# Drug_Target_2_GeneCard_ID:
MTAP

# Drug_Target_2_Gene_Name:
MTAP

# Drug_Target_2_Gene_Sequence:
>852 bp
ATGGCCTCTGGCACCACCACCACCGCCGTGAAGATTGGAATAATTGGTGGAACAGGCCTG
GATGATCCAGAAATTTTAGAAGGAAGAACTGAAAAATATGTGGATACTCCATTTGGCAAG
CCATCTGATGCCTTAATTTTGGGGAAGATAAAAAATGTTGATTGCATCCTCCTTGCAAGG
CATGGAAGGCAGCACACCATCATGCCTTCAAAGGTCAACTACCAGGCGAACATCTGGGCT
TTGAAGGAAGAGGGCTGTACACATGTCATAGTGACCACAGCTTGTGGCTCCTTGAGGGAG
GAGATTCAGCCCGGCGATATTGTCATTATTGATCAGTTCATTGACAGGACCACTATGAGA
CCTCAGTCCTTCTATGATGGAAGTCATTCTTGTGCCAGAGGAGTGTGCCATATTCCAATG
GCTGAGCCGTTTTGCCCCAAAACGAGAGAGGTTCTTATAGAGACTGCTAAGAAGCTAGGA
CTCCGGTGCCACTCAAAGGGGACAATGGTCACAATCGAGGGACCTCGTTTTAGCTCCCGG
GCAGAAAGCTTCATGTTCCGCACCTGGGGGGCGGATGTTATCAACATGACCACAGTTCCA
GAGGTGGTTCTTGCTAAGGAGGCTGGAATTTGTTACGCAAGTATCGCCATGGCGACAGAT
TATGACTGCTGGAAGGAGCACGAGGAAGCAGTTTCGGTGGACCGGGTCTTAAAGACCCTG
AAAGAAAACGCTAATAAAGCCAAAAGCTTACTGCTCACTACCATACCTCAGATAGGGTCC
ACAGAATGGTCAGAAACCCTCCATAACCTGAAGAATATGGCCCAGTTTTCTGTTTTATTA
CCAAGACATTAA

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
10404592	Appleby TC, Erion MD, Ealick SE: The structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase at 1.7 A resolution provides insights into substrate binding and catalysis. Structure. 1999 Jun 15;7(6):629-41.
7604019	Olopade OI, Pomykala HM, Hagos F, Sveen LW, Espinosa R 3rd, Dreyling MH, Gursky S, Stadler WM, Le Beau MM, Bohlander SK: Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6489-93.
8650244	Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL, Carson DA: Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6203-8.
8687427	Della Ragione F, Takabayashi K, Mastropietro S, Mercurio C, Oliva A, Russo GL, Della Pietra V, Borriello A, Nobori T, Carson DA, Zappia V: Purification and characterization of recombinant human 5'-methylthioadenosine phosphorylase: definite identification of coding cDNA. Biochem Biophys Res Commun. 1996 Jun 25;223(3):514-9.

# Drug_Target_2_HGNC_ID:
HGNC:7413

# Drug_Target_2_HPRD_ID:
01134

# Drug_Target_2_ID:
1958

# Drug_Target_2_Locus:
9p21

# Drug_Target_2_Molecular_Weight:
31236

# Drug_Target_2_Name:
S-methyl-5-thioadenosine phosphorylase

# Drug_Target_2_Number_of_Residues:
283

# Drug_Target_2_PDB_ID:
1SD2

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
>S-methyl-5-thioadenosine phosphorylase
MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLAR
HGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMR
PQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSR
AESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTL
KENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH

# Drug_Target_2_Reaction:
S-methyl-5'-thioadenosine + phosphate = adenine + S-methyl-5-thio-alpha-D-ribose 1-phosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Plays a major role in polyamine metabolism and is important for the salvage of both adenine and methionine

# Drug_Target_2_SwissProt_ID:
Q13126

# Drug_Target_2_SwissProt_Name:
MTAP_HUMAN

# Drug_Target_2_Synonyms:
5'- methylthioadenosine phosphorylase
EC 2.4.2.28
MTA phosphorylase
MTAPase

# Drug_Target_2_Theoretical_pI:
7.21

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02282
